MedPath

Ultrasound Guided Modified Pectoral Plane Block Versus Erector Spinae Plane Block During GA in Gynecomastia Surgery

Not Applicable
Completed
Conditions
Gynecomastia, Adolescent
Registration Number
NCT04221074
Lead Sponsor
Zagazig University
Brief Summary

Pain of breast surgery is due to chest wall scar and arm in some cases like carcinoma or due to nerve injury.It is neuropathic or nociceptive pain.Its severity is depending on the extent of surgery and the radiotherapy if needed.

Previous studies proved that local nerve block procedures improved the immediate postoperative pain and decreased the incidence of postoperative pain chronicity .

Also effective control of pain suppresses the surgical stress response minimizes the anaesthestic needs intraoperatively and decreases the opioid needs postoperatively .

Pectoralis nerve(pecs) II block and erector spinae plane (ESP) block are novel procedures that may provide good intraoperative and postoperative analgesia in patients undergoing surgical treatment of gynecomastia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
46
Inclusion Criteria
  • Male gender .
  • Age : 18 - 25 years old .
  • Physical status : ASA I - II .
  • Body mass index(BMI) :20-30 kg/m2
  • Surgical treatment of Gynecomastia .
  • Duration of surgery : 60 -120 min
Exclusion Criteria
  • Patient refusal .
  • History of opioid abuse or chronic analgesic use .
  • Coagulopathy .
  • Allergy to study drugs .
  • Infection in the injection sites.
  • Uncooperative patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
intraoperative analgesia60-120 minuets

measurement of bispectral index score

Secondary Outcome Measures
NameTimeMethod
postoperative analgesia24 hours

total opioid consumption (mg)

Trial Locations

Locations (1)

Zagazig university

🇪🇬

Zagazig, Egypt

Zagazig university
🇪🇬Zagazig, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.